NCT04829604 2026-03-09ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)Ambrx, Inc.Phase 2 Active not recruiting72 enrolled
NCT06504719 2025-09-15Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab GovitecanHellenic Cooperative Oncology GroupCompleted312 enrolled